PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance.
Tao ZhangQin LiuYingfan ZhuSongfa ZhangQiaohua PengAmanda Louise StricklandWenxin ZhengFeng ZhouPublished in: Cancer management and research (2021)
PD-L1 expression is frequently found in ESC, suggesting a potential role of the PD-1/PD-L1 pathway as a potential therapeutic target for these tumors. PD-L1 expression by TPS also serves as a negative prognostic marker in ESC and implies an unfavorable outcome.